Disruptive Technology Channel Disruptive Tech ETFs Rally on Encouraging Dialogue Between Russia and Ukraine By Max ChenMarch 29, 2022
Beyond Basic Beta Channel Vaccine Stocks Lift Biotech ETFs as China Enters Lockdowns By Max ChenMarch 14, 2022
Nasdaq Investment Intelligence Channel Traders Are Betting on a Quick Turnaround in Tech ETFs By Max ChenJanuary 26, 2022
Disruptive Technology Channel Innovative Tech ETFs Climb After Tesla’s Record Quarterly Deliveries By Max ChenJanuary 3, 2022
Disruptive Technology Channel Extended Inflation Doesn’t Have to Hobble Tech ETFs By Tom LydonOctober 29, 2021
ETF Building Blocks Channel Drug Price Debate May Not Hinder Biotech ETFs After All By Tom LydonSeptember 16, 2021
Featured Biotech ETFs Are Already Benefitting from Pfizer Vaccine’s Full Approval By Ian YoungAugust 23, 2021
Leveraged & Inverse Channel 4 Tech ETFs to Play the Current Chip Shortage By Ben HernandezJune 18, 2021
Innovative ETFs Channel Will Biotech ETFs Benefit from Biogen’s New Alzheimer’s Drug? By Ian YoungJune 9, 2021
